The clinical trials below are available in the specialty you selected. Choose a different specialty.

HIV Insomnia Study
If you are HIV positive and have trouble sleeping, you may be eligible to participate in this clinical trial. (REF# 18356)

Ritonavir Boosted Elvitegravir vs Raltegravir Study
This is a double blind safety and efficacy study of elvitegravir/ritonavir versus raltegravir in treatment experienced subjects. (REF# Pro00008911)

Structured Treatment Interruption Study
This study compares the effect of intermittent versus terminal treatment interruption for subjects started on ART during acute infection. (REF# 13570)

Optimizing Vaccine Responsiveness Study (ACTG A5232)
This is a pilot study investigating the extent of immune defects in people who have Hep C, HIV, or both by evaluating immune response to tetanus, Hep A and B antibodies. (REF# 2791)

HPV Vaccine in HIV+ Women (ACTG A5240 )
This is a study of safety and immune response to HPV vaccine in HIV infected females. (REF# 5156)

Optimized Treatment that Includes or Omits NRTI (ACTG A5241)
This is a randomized strategy study for treatment failure.
(REF# 3739)

Maraviroc Treatment for Suboptimal CD4 Count Recovery (ACTG A5256)
The purpose of this study is to assess if adding maraviroc to an existing suppressive Anti-Retroviral Therapy (ART) for 24 weeks will increase CD4 counts. (REF# 9854)